Align TechnologyXTER:AFW 89 OCF Yield % is 5.41 as of Jun. 29, 2026, which is 77% above its 10-year median of 3.06. GuruFocus rates XTER:AFW with a GF Score™ of 89/100 and a GF Value™ of €200.25 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Align Technology ranks better than 67.69% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Align Technology's OCF Yield % or its related term are showing as below:
XTER:AFW'
s OCF Yield % Range Over the Past 10 Years
Min: 1.19 Med: 3.06 Max: 7.98
Current: 5.41
During the past 13 years, the highest OCF Yield % of Align Technology was 7.98%. The lowest was 1.19%. And the median was 3.06%.
XTER:AFW's OCF Yield % is ranked better than 67.69% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 1.76
vs XTER:AFW: 5.41
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Align Technology OCF Yield % Related Terms
Align Technology OCF Yield % Historical Data
* Premium members only.
The historical data trend for Align Technology's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:AFW vs SOLV, COO, BAX: OCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, Align Technology's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Align Technology OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Align Technology's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Align Technology's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Align Technology (XTER:AFW) has a OCF Yield % of 5.41 as of Jun. 29, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Align Technology and its competitors. This is 77% above median its historical median of 3.06. Over the past decade, Align Technology's OCF Yield % has ranged from 1.19 to 7.98. According to the industry distribution chart, Align Technology ranks #275 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 32.3%.
Is Align Technology's OCF Yield % too high?
Align Technology's current OCF Yield % of 5.41 is 77% above median its 10-year median of 3.06. Over the past 10 years, this metric has ranged from a low of 1.19 to a high of 7.98. The Medical Devices & Instruments industry median OCF Yield % is 1.76. Align Technology's value of 5.41 is 207.4% above this industry median. Based on the distribution chart, Align Technology ranks #275 out of 851 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Align Technology has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Align Technology's OCF Yield % compare to SOLV and COO?
According to the Medical Devices & Instruments industry distribution chart, Align Technology ranks #275 out of 851 companies for OCF Yield %. This puts Align Technology in the upper half of its industry. The industry median OCF Yield % is 1.76. Align Technology's value of 5.41 is 207.4% above this benchmark. Historically, Align Technology's own OCF Yield % has ranged from 1.19 to 7.98 over the past decade. While the company's 10-year median is 3.06 vs. the industry median of 1.76, Align Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.76, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Align Technology's current OCF Yield % of 5.41 is 207.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Align Technology and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Align Technology's current OCF Yield % is 5.41, which is 77% above median its own 10-year median of 3.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Align Technology stock overvalued right now?
Based on GuruFocus' analysis, Align Technology (XTER:AFW) is currently considered Modestly Undervalued. The stock's GF Value™ is €200.25, compared to a current price of €149.05 — trading 25.6% below its estimated fair value. The current OCF Yield % is 5.41, which is 77% above median its 10-year median of 3.06 and 207.4% above the Medical Devices & Instruments industry median of 1.76. Align Technology's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Align Technology (XTER:AFW), the current OCF Yield % is 5.41 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Align Technology (XTER:AFW) Overvalued in 2026?
Based on GuruFocus' analysis, Align Technology stock appears to be undervalued.
The current stock price of €149.05 is trading 25.6% below its estimated GF Value™ of €200.25.
GuruFocus considers Align Technology to be Modestly Undervalued.
Key valuation signals for XTER:AFW:
OCF Yield %: 5.41 (77% above median its 10-year median of 3.06)
GF Value™: €200.25 vs. price of €149.05 (25.6% below fair value)
Industry Position: 207.4% above the Medical Devices & Instruments median (#275 of 851)
No single metric tells the full story. See the XTER:AFW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
89GF Score
Get the complete analysis for XTER:AFW
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:AFW has been successfully added to your 
